USD 29.96 billion
US, Europe, and Brazil Alopecia Market Size, Share, and Growth Analysis
US, Europe, and Brazil Alopecia Market By Disease Type (Androgenetic Alopecia, Alopecia Areata), By Treatment Type (Pharmaceuticals, Devices), By Gender (Male, Female), By Sales Channel (Prescriptions, OTC), By End-User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2361 |
Region:
Global |
Published Date: July, 2024
Pages:
165
|Tables:
50
|Figures:
74
Format -
US, Europe, and Brazil Alopecia Market Insights
US, Europe, and Brazil Alopecia Market size was valued at USD 29.96 billion in 2023 and is poised to grow from USD 32.27 billion in 2024 to USD 58.41 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The market for alopecia in US, Europe and Brazil has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.
The market for treating alopecia has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.
Over the course of the forecast period, the hair loss industry's market landscape is expected to be characterised by an increased focus on the provision of hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as by an increase in the penetration of cutting-edge hair loss treatment therapies like stem cell therapy. The number of people treated for hair loss is anticipated to increase with the advent of low-level laser therapy, which helps encourage hair growth. Additionally, the advent of laser hats, helmets, combs, and bands is anticipated to spur market expansion. The Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are a few of the cutting-edge goods available today.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Cosmetic Treatments & Products
Fastest Growth
Cosmetic Treatments & Products
Growth Rate
7.7% CAGR
US, Europe, & Brazil Alopecia Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
US, Europe, and Brazil Alopecia Market Segments Analysis
US, Europe, and Brazil Alopecia Market is segmented by Disease Type, Treatment Type, Gender, Sales Channel, End-User and region. Based on Disease Type, the market is segmented into Androgenetic Alopecia, Alopecia Areata, Cicatricial Alopecia, Traction Alopecia and Others. Based on Treatment Type, the market is segmented into Pharmaceuticals and Devices. Based on Gender, the market is segmented into Male and Female. Based on Sales Channel, the market is segmented into Prescriptions and OTC. Based on End-User, the market is segmented into Dermatology Clinics, Hospitals, Homecare Settings and Others. Based on region, the market is segmented into US, Europe and Brazil.
Analysis by Treatment
In 2023, the cosmetic treatments & products industry dominated the market and accounted for more than 58.37 % of total sales because they are pocket-friendly, easily available, and non-invasive. Such over-the-counter solutions give instant results with low-risk exposure and huge available variety for all needs. Huge marketing investments, celebrity endorsements propel their demand. Consumers like these quick, temporary, and customized solutions as they can be easily used and provide psychological relief by giving them a changed look within no time. Cosmetic treatments are one of the preferred choices in the management of alopecia because of its safety, effectiveness, and strong market presence.
According to our analysis cosmetic treatments and products for alopecia are the fastest growing with a CAGR of 8.1%. The factors contributing to their higher growth rate are that their appeal is very broad among the consumer base because of their availability over-the-counter and that most of them can be used without the supervision of medical professionals, which is what makes them rather cheap in price. The non-invasiveness and the fast visible results make these products and treatments appealing to users looking for an easy and quick solution. Innovation is continuous, and a wide array of customizable options caters to different needs, boosting growth further. On the other hand, heavy investments in marketing, including celebrity endorsements, help in better visibility and consumer trust. Therefore, all these factors combine to make cosmetic treatments the preferred and fastest-growing segment in the alopecia market.
US, Europe, & Brazil Alopecia Market By Treatment
To get detailed analysis on other segments, Request For Free Sample Report
US, Europe, and Brazil Alopecia Market Regional Insights
In 2023, US dominated the market and had the highest revenue share (60.01%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.
It is expected that the U.S. will be the fastest-growing region in the alopecia market, since it grows at the highest CAGR of all. The growth is mainly driven by increasing technological efforts and awareness programs being undertaken by both the government and commercial entities in the country. The other factor is extensive research on alopecia treatments done in the U.S. The outcome aids in better understanding, preventing, and managing the condition that lures investments and innovations in this field. Thus, the U.S. market characterizes the rapid growth in view of the swelling awareness, state-of-the-art technology, and well-funded research programs at almost every front to push it to the limelight of innovations in the treatment of alopecia.
US, Europe, & Brazil Alopecia Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
US, Europe, and Brazil Alopecia Market Dynamics
US, Europe, and Brazil Alopecia Market Drivers
Increasing Prevalence of Alopecia Areata Serves as a Significant Driving Factor for the Growth of the Alopecia Market
- According to SkyQuest’s analysis, the rising incidence of alopecia areata drives the alopecia market in the North America region. This disease affects 6.7 million in the U.S. and 160 million in the world, making the market large in opportunity. Alopecia does not favours anybody; it affects both men and women; patient constitutions span all age groups. Up to 9 percent of relatives are affected, hinting at a potential hereditary link. It complicates the treatment of alopecia areata through possible comorbidity with other autoimmune diseases, and hence complex and innovative treatments are needed. The high demand for remedial solutions results from the collective operation of all these factors, which helps the alopecia market grow substantially.
Surge In Product Approvals for Alopecia Treatment Is propelling the Growth of Alopecia Market
- Product approvals are surging really to revolutionize the management of alopecia and drive market growth, which bellwethers the pharmaceutical industries' focus on the unmet needs of patients. Among the key highlights include the June 2023 FDA approval of LITFULO (ritlecitinib) made by Pfizer for adolescents with severe alopecia areata, furthermore, in June 2023, Cosmo Pharmaceuticals N.V. announced the initiation of phase III trials of clascoterone solution. These developments underline the commitment of the sector to therapeutic innovation, leading to improved outcomes and a better quality of life for patients, which therefore helps drive another dynamic and expanding alopecia treatment market.
US, Europe, and Brazil Alopecia Market Restraints
High Cost of Alopecia Treatment Restraints the Alopecia Market Growth
- The high expense of the treatment, on the other hand, impede the market's rate of expansion. The market for alopecia areata will be challenged by limited primary care services and a lack of healthcare infrastructure in emerging nations. During the projection period of 2024–2031, strong regulatory rules and a lack of public awareness will also act as inhibitors and slow down-market growth.
Hold On Clinical Trials for Alopecia Treatment Represents a Significant Hindrance to the Growth of the Alopecia Market:
- Clinical trials for the treatment of alopecia are put on hold, which creates substantial pressure on this market's growth because the development and approval of new therapy episodes are really delayed. The holds, usually regarding safety concerns, as seen in the case of Sun Pharmaceutical with deuruxolitinib in May 2023, provoke discontinuation in the trial progress and raise concerns about the safety profile. Such regulatory actions demand that enrollment be put on hold while extra safety assessments are carried out, ultimately leading to prolonged timelines and increased costs. Thus, these delays undermine investor confidence by halting further R&D investment and making the innovative therapy pipeline stagnant. Patients are made to suffer for a longer period of time without much access to new treatments, as a market progresses slowly.
Request Free Customization of this report to help us to meet your business objectives.
US, Europe, and Brazil Alopecia Market Competitive Landscape
Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion.
Top Players in US, Europe, and Brazil Alopecia Market
- Pfizer Inc. (United States)
- Eli Lilly and Company (United States)
- AbbVie Inc. (United States)
- Aclaris Therapeutics, Inc. (United States)
- Concert Pharmaceuticals, Inc. (United States)
- Sanofi SA (France)
- GlaxoSmithKline PLC (United Kingdom)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Ache Laboratorios Farmaceuticos S.A. (Brazil)
- EMS Pharma (Brazil)
Recent Development
- In June 2023, Pfizer Inc. disclosed that the U.S. Food and Drug Administration (FDA) has granted approval for LITFULO (ritlecitinib), an oral treatment taken once daily, for individuals aged 12 and above with severe alopecia areata. The FDA's approval recommends a dosage of 50 mg for LITFULO. Notably, LITFULO is the first and sole treatment sanctioned by the FDA for adolescents aged 12 and older grappling with severe alopecia areata.
- In June 2022, Eli Lilly and Company and Incyte jointly announced that the U.S. Food and Drug Administration (FDA) has granted approval for OLUMIANT (baricitinib), a once-daily pill, as the first systemic treatment for adults with severe alopecia areata (AA). OLUMIANT is available in 4-mg, 2-mg, and 1-mg tablets, with the recommended dosage being OLUMIANT 2-mg/day initially. If the treatment response is inadequate, the dosage may be increased to 4-mg/day. For patients experiencing nearly complete or total scalp hair loss, with or without significant eyelash or eyebrow hair loss, treatment with 4-mg/day is advised. Upon achieving an adequate response with 4-mg/day, the dosage should be reduced to 2-mg/day. It's important to note that OLUMIANT is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants.
US, Europe, and Brazil Alopecia Key Market Trends
- Integration of Telemedicine & Remote Patient Consultations: Telemedicine is revolutionizing health care. It is facilitating access for alopecia patients through companies like TelMDcare. Virtual consultations to dermatologists allow home diagnosis and treatment, thus increasing access and convenience. This will facilitate timely interventions to be effected since symptoms can track the development of hair loss. It expands a healthcare provider's patient base to the remote and underserved populations, covering gaps in access to specialized care. Moreover, the application of telemedicine will help health providers bring alopecia patients closer to management, thus improving patients' outcomes and overall satisfaction considerably.
- Focus on Natural & Organic Hair Loss Solutions: The alopecia market is increasing the offering of natural and organic solutions because of the trend of cleaner and more sustainable beauty. Companies at the helm of innovation, such as L'Oreal, are working on hair care products crafted with natural ingredients and botanical extracts that can enhance hair growth and scalp health. This trend speaks to consumers who are looking for safe, green alternatives to traditional treatments. Brands are, therefore, banking on this clean beauty to create a sweet market niche for themselves while at the same time leading in product innovation. This not only aids brands in aligning themselves with consumer preference but also enhances overall growth and sustainability in the market.
US, Europe, and Brazil Alopecia Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the alopecia areata segment dominated the US, Europe, and Brazil Alopecia Market in 2023 and is expected to maintain its dominance throughout the forecast period. In 2023, US dominated the US, Europe, and Brazil Alopecia Market owing to the region's increase in customer awareness and government strict regulation on plastic.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 29.96 billion |
| Market size value in 2032 | USD 58.41 billion |
| Growth Rate | 7.7% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on US, Europe, and Brazil Alopecia Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on US, Europe, and Brazil Alopecia Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the US, Europe, and Brazil Alopecia Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the US, Europe, and Brazil Alopecia Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the US, Europe, and Brazil Alopecia Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the US, Europe, and Brazil Alopecia Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
